2016 VAM: 3305 - Severe Asthma in Children: From Mechanisms to Disease Modification
Frequent exacerbations are an important feature and associated with significant morbidity, health care utilization and costs.Furthermore, recurrent severe exacerbations may lead to progressive loss of lung function and increased asthma severity over time.Recent studies have helped elucidate mechanisms underlying severe asthma in children. With the emergence of biologic therapies, there has been interest in their role in the prevention of asthma exacerbations and potential utility for disease modification.
AMA PRA Category 1 Credits™: 1.25
Credit must be claimed by May 31, 2018. Any credit request on or after June 1, 2018 will be subject to an administrative fee.
Allied Health Professionals
Upon completion of this activity, participants will be able to:
1. Describe the frequency and common features of severe asthma in children
2. Identify common underlying mechanisms of severe asthma in children
3. Discuss the efficacy of omalizumab and the potential for disease modification in children
Leonard B. Bacharier, MD FAAAAI, Washington University School of Medicine and St. Louis Children, Saint Louis, MO
Dr. Theresa W. Guilbert, MD MS, Cincinnati Children's Hospital & Medical Center, Cincinnati, OH
Dr. Daniel J. Jackson, MD, Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI
- 1.25 AttendanceAttendance credit.
- 1.25 CECE credit.
- 1.25 CMECME credit.